Research ArticleLaboratory Studies
Gallium-67/Gallium-68-[DFO]-Octreotide—A Potential Radiopharmaceutical for PET Imaging of Somatostatin Receptor-Positive Tumors: Synthesis and Radiolabeling In Vitro and Preliminary In Vivo Studies
Peter M. Smith-Jones, Barbara Stolz, Christian Bruns, Rainer Albert, Hans W. Reist, Raimund Fridrich and Helmut R. Mäcke
Journal of Nuclear Medicine February 1994, 35 (2) 317-325;
Peter M. Smith-Jones
Barbara Stolz
Christian Bruns
Rainer Albert
Hans W. Reist
Raimund Fridrich


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Gallium-67/Gallium-68-[DFO]-Octreotide—A Potential Radiopharmaceutical for PET Imaging of Somatostatin Receptor-Positive Tumors: Synthesis and Radiolabeling In Vitro and Preliminary In Vivo Studies
Peter M. Smith-Jones, Barbara Stolz, Christian Bruns, Rainer Albert, Hans W. Reist, Raimund Fridrich, Helmut R. Mäcke
Journal of Nuclear Medicine Feb 1994, 35 (2) 317-325;
Gallium-67/Gallium-68-[DFO]-Octreotide—A Potential Radiopharmaceutical for PET Imaging of Somatostatin Receptor-Positive Tumors: Synthesis and Radiolabeling In Vitro and Preliminary In Vivo Studies
Peter M. Smith-Jones, Barbara Stolz, Christian Bruns, Rainer Albert, Hans W. Reist, Raimund Fridrich, Helmut R. Mäcke
Journal of Nuclear Medicine Feb 1994, 35 (2) 317-325;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET
- Multiparametric Monitoring of Tumor Response to Chemotherapy by Noninvasive Imaging
- 68Ga-Labeled Peptides in Tumor Imaging
- Reagents and Methods for PET Using Bispecific Antibody Pretargeting and 68Ga-Radiolabeled Bivalent Hapten-Peptide-Chelate Conjugates
- 110mIn-DTPA-D-Phe1-Octreotide for Imaging of Neuroendocrine Tumors with PET